C. Gregory Peters
Stock Analyst at Raymond James
(4.80)
# 63
Out of 4,829 analysts
203
Total ratings
73.4%
Success rate
14.27%
Average return
Main Sectors:
Stocks Rated by C. Gregory Peters
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EG Everest Group | Reiterates: Strong Buy | $420 → $410 | $348.04 | +17.80% | 2 | May 6, 2025 | |
| ALL The Allstate Corporation | Reiterates: Strong Buy | $240 → $250 | $202.64 | +23.37% | 24 | May 5, 2025 | |
| HIG The Hartford Insurance Group | Maintains: Outperform | $125 → $135 | $127.52 | +5.87% | 7 | Mar 31, 2025 | |
| HQY HealthEquity | Upgrades: Strong Buy | $120 → $115 | $90.44 | +27.16% | 12 | Mar 25, 2025 | |
| MCY Mercury General | Upgrades: Strong Buy | $70 → $80 | $60.19 | +32.91% | 6 | Feb 12, 2025 | |
| MMC Marsh & McLennan Companies | Reiterates: Outperform | $240 → $250 | $226.85 | +10.20% | 17 | Feb 6, 2025 | |
| KMPR Kemper | Maintains: Strong Buy | $75 → $82 | $64.28 | +27.57% | 13 | Dec 26, 2024 | |
| HGTY Hagerty | Downgrades: Underperform | n/a | $9.76 | - | 2 | Dec 26, 2024 | |
| PGR The Progressive Corporation | Upgrades: Outperform | $305 | $284.51 | +7.20% | 20 | Dec 26, 2024 | |
| WTW Willis Towers Watson | Upgrades: Strong Buy | $365 → $400 | $309.07 | +29.42% | 10 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $16 | $11.16 | +43.37% | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $45 → $55 | $59.87 | -8.13% | 8 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $110 | $111.32 | -1.19% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $40 → $45 | $38.82 | +15.92% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $270 → $285 | $289.88 | -1.68% | 8 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $220 → $245 | $269.75 | -9.18% | 7 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $338.18 | - | 18 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $255 → $260 | $309.50 | -15.99% | 8 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $29 → $30 | $37.91 | -20.87% | 8 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $354.32 | - | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $147.80 | - | 1 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $74.62 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $67 | $105.97 | -36.77% | 2 | Feb 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.20 | - | 4 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $41.97 | - | 1 | Feb 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.12 | - | 4 | Feb 1, 2021 |
Everest Group
May 6, 2025
Reiterates: Strong Buy
Price Target: $420 → $410
Current: $348.04
Upside: +17.80%
The Allstate Corporation
May 5, 2025
Reiterates: Strong Buy
Price Target: $240 → $250
Current: $202.64
Upside: +23.37%
The Hartford Insurance Group
Mar 31, 2025
Maintains: Outperform
Price Target: $125 → $135
Current: $127.52
Upside: +5.87%
HealthEquity
Mar 25, 2025
Upgrades: Strong Buy
Price Target: $120 → $115
Current: $90.44
Upside: +27.16%
Mercury General
Feb 12, 2025
Upgrades: Strong Buy
Price Target: $70 → $80
Current: $60.19
Upside: +32.91%
Marsh & McLennan Companies
Feb 6, 2025
Reiterates: Outperform
Price Target: $240 → $250
Current: $226.85
Upside: +10.20%
Kemper
Dec 26, 2024
Maintains: Strong Buy
Price Target: $75 → $82
Current: $64.28
Upside: +27.57%
Hagerty
Dec 26, 2024
Downgrades: Underperform
Price Target: n/a
Current: $9.76
Upside: -
The Progressive Corporation
Dec 26, 2024
Upgrades: Outperform
Price Target: $305
Current: $284.51
Upside: +7.20%
Willis Towers Watson
Dec 5, 2024
Upgrades: Strong Buy
Price Target: $365 → $400
Current: $309.07
Upside: +29.42%
Nov 12, 2024
Maintains: Outperform
Price Target: $15 → $16
Current: $11.16
Upside: +43.37%
Nov 5, 2024
Maintains: Strong Buy
Price Target: $45 → $55
Current: $59.87
Upside: -8.13%
Jul 25, 2024
Maintains: Outperform
Price Target: $95 → $110
Current: $111.32
Upside: -1.19%
May 22, 2024
Reiterates: Strong Buy
Price Target: $40 → $45
Current: $38.82
Upside: +15.92%
Feb 1, 2024
Maintains: Strong Buy
Price Target: $270 → $285
Current: $289.88
Upside: -1.68%
Jan 22, 2024
Maintains: Strong Buy
Price Target: $220 → $245
Current: $269.75
Upside: -9.18%
Dec 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $338.18
Upside: -
Nov 2, 2023
Maintains: Outperform
Price Target: $255 → $260
Current: $309.50
Upside: -15.99%
Oct 30, 2023
Maintains: Outperform
Price Target: $29 → $30
Current: $37.91
Upside: -20.87%
Oct 31, 2022
Downgrades: Underperform
Price Target: n/a
Current: $354.32
Upside: -
Sep 23, 2022
Initiates: Market Perform
Price Target: n/a
Current: $147.80
Upside: -
Jun 7, 2022
Initiates: Market Perform
Price Target: n/a
Current: $74.62
Upside: -
Feb 7, 2022
Maintains: Outperform
Price Target: $60 → $67
Current: $105.97
Upside: -36.77%
Aug 12, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $8.20
Upside: -
Feb 19, 2021
Initiates: Market Perform
Price Target: n/a
Current: $41.97
Upside: -
Feb 1, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $5.12
Upside: -